Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dubuc

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Nature Neuroscience|August 11, 2015
EAG2 potassium channel with evolutionarily conserved function as a brain tumor targetXi Huang, Ye He, Adrian M Dubuc, et al.
Neuro-Oncology|September 11, 2021
A molecularly integrated grade for meningiomaJoseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.
Cancer Research|October 11, 2022
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of MedulloblastomaAnna Borgenvik, Karl O Holmberg, Sara Bolin, et al.
Cancer Research|January 25, 2019
<i>Sleeping Beauty</i> Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal TumorsPauline J Beckmann, Jon D Larson, Alex T Larsson, et al.
Neuro-Oncology|January 21, 2017
Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumorsShakti H Ramkissoon, Pratiti Bandopadhayay, Jaeho Hwang, et al.
Nature Communications|May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibitionJan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
The Lancet. Oncology|October 22, 2013
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
JCI Insight|November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer populationLynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Nature|February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyS C Mack, H Witt, R M Piro, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Nature Neuroscience|August 11, 2015
EAG2 potassium channel with evolutionarily conserved function as a brain tumor targetXi Huang, Ye He, Adrian M Dubuc, et al.
Neuro-Oncology|September 11, 2021
A molecularly integrated grade for meningiomaJoseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.
Cancer Research|October 11, 2022
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of MedulloblastomaAnna Borgenvik, Karl O Holmberg, Sara Bolin, et al.
Cancer Research|January 25, 2019
<i>Sleeping Beauty</i> Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal TumorsPauline J Beckmann, Jon D Larson, Alex T Larsson, et al.
Neuro-Oncology|January 21, 2017
Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumorsShakti H Ramkissoon, Pratiti Bandopadhayay, Jaeho Hwang, et al.
Nature Communications|May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibitionJan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
The Lancet. Oncology|October 22, 2013
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.
JCI Insight|November 25, 2016
Institutional implementation of clinical tumor profiling on an unselected cancer populationLynette M Sholl, Khanh Do, Priyanka Shivdasani, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Nature|February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyS C Mack, H Witt, R M Piro, et al.
Pageof 12